Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
NMRA holding history
Neumora Therapeutics, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NMRA overviewAll 13F holders of NMRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,278,408
- Value
- $2.17M
- % of portfolio
- 0.4%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,278,408 | $2.17M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,278,408 | $2.49M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,278,408 | $2.29M | 0.3% | +1,265,910+10,128.9% | Added | Holders |
| Q3 2025 | 12,498 | $22.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 12,498 | $9.16K | <0.1% | −2,959−19.1% | Reduced | Holders |
| Q1 2025 | 15,457 | $15.5K | <0.1% | +15,457 | New | Holders |